Literature DB >> 20219984

Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice.

Prasanna Krishnamurthy1, Erin Lambers, Suresh Verma, Tina Thorne, Gangjian Qin, Douglas W Losordo, Raj Kishore.   

Abstract

Prolonged inflammatory response is associated with left ventricular (LV) dysfunction and adverse remodeling following myocardial infarction (MI). IL-10 inhibits inflammation by suppressing HuR-mediated mRNA stabilization of proinflammatory cytokines. Here we report that following MI, IL-10(-/-) mice showed exaggerated LV dysfunction, fibrosis, and cardiomyocyte apoptosis. Short-hairpin RNA (shRNA)-mediated knockdown of HuR in the myocardium significantly reversed MI-induced LV dysfunctions and LV remodeling. HuR knockdown significantly reduced MI-induced cardiomyocyte apoptosis concomitant with reduced p53 expression. Moreover, HuR knockdown significantly reduced infarct size and fibrosis area, which in turn was associated with decreased TGF-beta expression. In vitro, stable knockdown of HuR in mouse macrophage cell line RAW 264.7 corroborated in vivo data and revealed reduced mRNA expression of TNF-alpha, TGF-beta, and p53 following LPS challenge, which was associated with a marked reduction in the mRNA stability of these genes. Taken together, our studies suggest that HuR is a direct target of IL-10, and HuR knockdown mimics anti-inflammatory effects of IL-10.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219984      PMCID: PMC2887267          DOI: 10.1096/fj.09-149815

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury.

Authors:  Z Yang; B Zingarelli; C Szabó
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Gene suppression by tristetraprolin and release by the p38 pathway.

Authors:  W Zhu; M A Brauchle; F Di Padova; H Gram; L New; K Ono; J S Downey; J Han
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-08       Impact factor: 5.464

3.  p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes.

Authors:  X Long; M O Boluyt; M L Hipolito; M S Lundberg; J S Zheng; L O'Neill; C Cirielli; E G Lakatta; M T Crow
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis.

Authors:  K Suzuki; B Murtuza; R T Smolenski; I A Sammut; N Suzuki; Y Kaneda; M H Yacoub
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway.

Authors:  E Carballo; H Cao; W S Lai; E A Kennington; D Campbell; P J Blackshear
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

6.  IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.

Authors:  N G Frangogiannis; L H Mendoza; M L Lindsey; C M Ballantyne; L H Michael; C W Smith; M L Entman
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events.

Authors:  Matthias Girndt; Harald Kaul; Urban Sester; Christof Ulrich; Martina Sester; Thomas Georg; Hans Köhler
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

8.  Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase.

Authors:  S Kuga; T Otsuka; H Niiro; H Nunoi; Y Nemoto; T Nakano; T Ogo; T Umei; Y Niho
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

9.  Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation.

Authors:  Stacey L Cohen; Aideen M Moore; Wendy E Ward
Journal:  Inflamm Bowel Dis       Date:  2004-09       Impact factor: 5.325

10.  HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells.

Authors:  H Hasegawa; W Kakuguchi; T Kuroshima; T Kitamura; S Tanaka; Y Kitagawa; Y Totsuka; M Shindoh; F Higashino
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

View more
  41 in total

1.  Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.

Authors:  Prasanna Krishnamurthy; Melissa Thal; Suresh Verma; Eneda Hoxha; Erin Lambers; Veronica Ramirez; Gangjian Qin; Douglas Losordo; Raj Kishore
Journal:  Circ Res       Date:  2011-09-29       Impact factor: 17.367

2.  Cardiac cell therapy: the next (re)generation.

Authors:  Elvira Forte; Isotta Chimenti; Lucio Barile; Roberto Gaetani; Francesco Angelini; Vittoria Ionta; Elisa Messina; Alessandro Giacomello
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 3.  The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins.

Authors:  Alessia Pascale; Stefano Govoni
Journal:  Cell Mol Life Sci       Date:  2011-09-10       Impact factor: 9.261

4.  Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.

Authors:  Suresh K Verma; Venkata N S Garikipati; Prasanna Krishnamurthy; Sarah M Schumacher; Laurel A Grisanti; Maria Cimini; Zhongjian Cheng; Mohsin Khan; Yujia Yue; Cindy Benedict; May M Truongcao; Joseph E Rabinowitz; David A Goukassian; Douglas Tilley; Walter J Koch; Raj Kishore
Journal:  Circulation       Date:  2017-06-30       Impact factor: 29.690

5.  Enhancer-associated long noncoding RNAs: A novel frontier with new perception in cardiac regeneration.

Authors:  Prince Jeyabal; Rajarajan A Thandavarayan; Sahana Suresh Babu; Prasanna Krishnamurthy
Journal:  Trends Cardiovasc Med       Date:  2015-02-23       Impact factor: 6.677

Review 6.  Sensing the cardiac environment: exploiting cues for regeneration.

Authors:  Maria José Nunes Pereira; Isabel Fidalgo Carvalho; Jeffrey M Karp; Lino S Ferreira
Journal:  J Cardiovasc Transl Res       Date:  2011-07-07       Impact factor: 4.132

Review 7.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

8.  The induced RNA-binding protein, HuR, targets 3'-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis.

Authors:  K Ouhara; S Munenaga; M Kajiya; K Takeda; S Matsuda; Y Sato; Y Hamamoto; T Iwata; S Yamasaki; K Akutagawa; N Mizuno; T Fujita; E Sugiyama; H Kurihara
Journal:  Clin Exp Immunol       Date:  2018-03-08       Impact factor: 4.330

9.  Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.

Authors:  Samuel Slone; Sarah R Anthony; Xiaoqing Wu; Joshua B Benoit; Jeffrey Aube; Liang Xu; Michael Tranter
Journal:  Cell Signal       Date:  2016-08-10       Impact factor: 4.315

10.  Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats.

Authors:  Kui-Po Yan; Yong Guo; Zhihua Xing; Xi Huang; Shengping Dai; Min Duan; Xinhua Sun; Wei Huang; Weijun Peng
Journal:  Exp Ther Med       Date:  2011-12-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.